Address: IMS HEALTH
Europaplatz 3 / Stiege 4 / 6. Stock
1150 Wien
,Austria
Tel: +43 (0) 1 78 00 2
Web: http://www.imshealth.com/portal/site/ims
IMS Health is a leading provider of information, services and technology for the healthcare industry, covering markets in 100+ countries around the world. A market leader for more than 25 years. IMS blends industry expertise and advanced technology to deliver the most accurate perspectives and in-depth analytics on healthcare dynamics. Actionable insights, powered by superior information assets, are tuned to clients’ precise requirements.
The IMS team counts up to 5.000 employees worldwide. The Austrian affiliate serves their clients with a team of 24 seasoned people and has the pleasure to cooperate with over 850 doctors, 280 pharmacies, 120 hospitals and nearly all operating wholesalers.
IMS continuously innovates to keep pace with a global healthcare environment that is increasingly complex and interdependent. Whether the clients are decision makers in life sciences, payers, providers or policymakers, the analytical, commercial IMS services and consulting capabilities are key to competitive advantage — and to achieving high-quality, cost-effective healthcare.
Michael Krebs, managing director of the Institute of Molecular Biotechnology (IMBA), the leading publicly funded non-university biomedical research organization in Austria, provides an overview of IMBA’s role in the Austrian…
Christina Nageler, managing director of the Austrian Self Care Association (IGEPHA), the representative voice of the Austrian OTC community, provides an insight into the obstacles associated with the sale of…
Wolfgang Jank, general manager and founder, and Tina Theuer, managing partner, of first pharma J.M.T. GmbH, a young Austrian pharmaceutical service company, discuss the challenges of founding a new business…
Philipp von Lattorff, country managing director of Boehringer Ingelheim’s Regional Centre Vienna (RCV) discusses the current mandate of the center and the dynamic performance of its 33 members, as well…
Prof. Johannes Khinast, CEO and scientific director, and Dr. Thomas Klein, CEO and business director of the Research Center Pharmaceutical Engineering, or RCPE, the world’s first pharmaceutical engineering company that…
Dr. Andrea Podczeck-Schweighhofer, president of the Austrian Society of Cardiology, the representative voice of the Austrian cardiology ecosystem, provides an overview into the challenges associated with research in Austria and…
Sylvia Hofinger, director general of the Association of the chemical industry of Austria (FCIO), the representing voice of the Austrian chemical industry, discusses the drug pricing regulations that are affecting…
Karsten Schlemm MD, CEO of Merz Pharma Austria, a leading international German based aesthetic company, provides an in-depth look into the company´s transformation from pharmaceuticals to the aesthetics sector as…
Manuel Reiberg, president of the Forum of the Research-Based Pharmaceutical Industry in Austria (FOPI), which represents the 27 leading pharmaceutical innovators in Austria focused on pharmaceutical innovation, discusses the struggles…
Herwig Ostermann, executive director of the Austrian Public Health Institute (GOeG), a neutral entity that brings expertise and evidence together to help plan and promote Austrian healthcare, provides insights into…
Dr. Erwin Klein, CEO and co-founder of easypharm, a generics and OTC company founded by Austrians for Austria, provides an overview of his exciting entrepreneurial experience and the challenges associated…
Ana Kostova, Austrian country president for AstraZeneca, a global powerhouse in innovative drugs and R&D, discusses the opportunities and challenges of introducing innovative treatments into the Austrian healthcare system as…
See our Cookie Privacy Policy Here
